Abstract
This study evaluates tolerability and efficacy of a nanosilicon-based spray formula in 34 patients with mild and/or moderate atopic dermatitis. A marked improvement of the symptoms was achieved in 85% of cases, and an unremarkable one in 15% of cases. The product was always well tolerated and never caused side effects.
Original language | English |
---|---|
Pages (from-to) | 27-30 |
Number of pages | 4 |
Journal | European Journal of Pediatric Dermatology |
Volume | 18 |
Issue number | 1 |
Publication status | Published - 2008 |
Keywords
- Atopic dermatitis
- Nanosilicon
ASJC Scopus subject areas
- Dermatology
- Pediatrics, Perinatology, and Child Health